Statement by Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on Senate Vote to Restore FDA Sequestered User Fees

JANUARY 15, 2014
PRESS RELEASE

WASHINGTON DC, (January 16, 2014) — Today, the U.S. Senate joined the House of Representatives in voting to restore $85 million in Food and Drug Administration (FDA) sequestered user fees, reflecting bipartisan recognition of the critical need to ensure the agency has the resources required to carry out its mission, including the review and approval of affordable generic medicines and biosimilars.

GPhA would especially like to congratulate Senate Agriculture and FDA Appropriations Subcommittee Chair Mark Pryor and Ranking Member Roy Blunt for their unwavering commitment to restoring industry-supported FDA user fees and ensuring that millions of Americans have timely access to more affordable generic medicines.

View the January 15 press release here.

SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.